piracetam has been researched along with 4-phenylpiracetam in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (77.78) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, DE; L'Italien, YJ; Marriott, JG; Nordin, IC; Poschel, PH; Zweisler, L | 1 |
| Bobkov, IuG; Glozman, OM; Morozov, IS; Nerobkova, LN; Zhmurenko, LA | 1 |
| Kim, S; Lho, DS; Myung, SW; Park, JH | 1 |
| Il'iaĭnen, EV; Koval'chuk, IV; Koval'chuk, VV; Melikhova, EV; Skoromets, AA; Stoianova, EG; Vysotskaia, ML | 1 |
| Dambrova, M; Grinberga, S; Kalvinsh, I; Svalbe, B; Veinberg, G; Vorona, M; Zvejniece, L | 1 |
| Berestovitskaia, VM; Luzhnova, SA; Samotrueva, MA; Serezhnikova, TK; Teplyĭ, DL; Tiurenkov, IN; Vasil'eva, OS | 1 |
| Khlebtsova, EB; Magomedov, MM; Samotrueva, MA; Tiurenkov, IN | 1 |
| Khlebtsova, EB; Samotrueva, MA; Serezhnikova, TK; Teplyi, DL; Tyurenkov, IN | 1 |
| Iakunina, AV; Kalinin, VA; Kurov, MV; Poverennova, IE | 1 |
| Priluchnyĭ, SV; Samotrueva, MA; Tiurenkov, IN | 1 |
| Avakian, GN; Badalian, OL; Savenkov, AA | 1 |
| Akhapkin, RV; Akhapkina, VI | 1 |
| Liubimov, AV | 1 |
| Epifanov, AV; Frolova, VI; Medvedev, VE | 1 |
| Fedin, AI; Fedotova, AV; Mironova, OP; Solov'eva, ÉI | 1 |
| Mamchur, VI; Pavlov, SV; Zhiliuk, VI | 1 |
| Samotrueva, MA; Tsibizova, AA; Tyurenkov, IN; Yasenyavskaya, AL | 1 |
| Dambrova, M; Grinberga, S; Stelfa, G; Svalbe, B; Vavers, E; Videja, M; Zvejniece, B; Zvejniece, L | 1 |
4 trial(s) available for piracetam and 4-phenylpiracetam
| Article | Year |
|---|---|
[Efficacy of phenotropil in the rehabilitation of stroke patients].
Topics: Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piracetam; Recovery of Function; Severity of Illness Index; Stroke; Stroke Rehabilitation; Treatment Outcome | 2010 |
[Nootropics and antioxidants in the complex therapy of symptomatic posttraumatic epilepsy].
Topics: Adolescent; Adult; Antioxidants; Cognition; Drug Therapy, Combination; Electroencephalography; Epilepsy, Post-Traumatic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nootropic Agents; Picolines; Piracetam; Treatment Outcome; Young Adult | 2013 |
[The use of phenotropil in vertebrobasilar insufficiency].
Topics: Aged; Female; Humans; Male; Middle Aged; Piracetam; Vertebrobasilar Insufficiency | 2013 |
[New possibilities of pharmacotherapy in cardiovascular patients with mental disorders].
Topics: Cardiovascular Diseases; Depressive Disorder; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Nootropic Agents; Pantothenic Acid; Piracetam; Stress, Psychological | 2014 |
14 other study(ies) available for piracetam and 4-phenylpiracetam
| Article | Year |
|---|---|
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
Topics: Amnesia; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Humans; Male; Mice; Mice, Inbred Strains; Pyrrolidines; Structure-Activity Relationship | 1984 |
[Pharmacological characteristics of a new phenyl analog of piracetam--4-phenylpiracetam].
Topics: Animals; Anticonvulsants; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Epilepsies, Partial; Guinea Pigs; Mice; Morpholines; Nystagmus, Physiologic; Piracetam; Pyrrolidinones; Rats | 1983 |
Determination of carphedon in human urine by solid-phase microextraction using capillary gas chromatography with nitrogen-phosphorus detection.
Topics: Central Nervous System Stimulants; Chromatography, Gas; Humans; Piracetam; Substance Abuse Detection | 1999 |
Investigation into stereoselective pharmacological activity of phenotropil.
Topics: Animals; Antidepressive Agents; Central Nervous System; Chromatography, Liquid; Male; Memory; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Motor Activity; Piracetam; Stereoisomerism; Swimming; Tandem Mass Spectrometry | 2011 |
[Phenotropyl succinate as the means for correction of neuroimmune disturbances under conditions of informational-physical stress].
Topics: Animals; Antibodies; Behavior, Animal; Erythrocytes; Female; Food Deprivation; Hemagglutination Tests; Immunity, Cellular; Immunity, Humoral; Immunization; Injections, Intraperitoneal; Leukocyte Count; Lipid Peroxidation; Maze Learning; Neuroprotective Agents; Phagocytosis; Physical Exertion; Piracetam; Rats; Rats, Wistar; Sheep; Stress, Physiological; Succinic Acid | 2011 |
[Influence of GABA derivatives on some indices of lipid peroxidation in immunocompetent organs under experimental immunopathology conditions].
Topics: Animals; Antioxidants; Baclofen; Catalase; Cyclophosphamide; gamma-Aminobutyric Acid; Immunosuppression Therapy; Immunosuppressive Agents; Lipid Peroxidation; Lipopolysaccharides; Male; Malondialdehyde; Organ Specificity; Oxidative Stress; Piracetam; Rats; Rats, Wistar; Spleen; Thymus Gland | 2011 |
Psychoimmunomodulatory effect of phenotropil in animals with immune stress.
Topics: Animals; Antibodies; Anxiety; Behavior, Animal; Hemagglutination Inhibition Tests; Hypersensitivity, Delayed; Immune System; Immunomodulation; Injections, Intraperitoneal; Lipopolysaccharides; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Neutrophils; Phagocytosis; Piracetam; Pseudomonas aeruginosa; Rats; Rats, Wistar | 2011 |
[Phenotropil in the complex treatment of symptomatic post traumatic epilepsy].
Topics: Adult; Combined Modality Therapy; Epilepsies, Partial; Epilepsy, Post-Traumatic; Female; Humans; Male; Piracetam; Young Adult | 2011 |
[Psychomodulating activity of phenotropil in experimental hyperthyroidism].
Topics: Animals; Behavior, Animal; Disease Models, Animal; Female; Hyperthyroidism; Neuroprotective Agents; Piracetam; Rats; Rats, Wistar | 2013 |
[Identification and evaluation of the neuroleptic activity of phenotropil].
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Male; Mice; Motor Activity; Piracetam; Psychotic Disorders; Rats; Treatment Outcome | 2013 |
[Treatment of asthenic syndrome in patients with chronic brain ischemia: results of the non-interventional observational program TRIUMPH].
Topics: Aged; Aged, 80 and over; Asthenia; Brain Ischemia; Chronic Disease; Female; Humans; Male; Middle Aged; Neurasthenia; Piracetam; Syndrome; Treatment Outcome | 2014 |
[Role of functional state of neuronal mitochondria of cerebral cortex in mechanisms of nootropic activity of neuroprotectors in rats with alloxan hyperglycemia].
Topics: Alloxan; Amnesia; Animals; Avoidance Learning; Cerebral Cortex; Cognition; Cytidine Diphosphate Choline; Diabetes Mellitus, Experimental; Dipeptides; Hyperglycemia; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neurons; Nootropic Agents; Pentoxifylline; Piracetam; Rats; Rats, Wistar | 2015 |
[PHENOTROPIL AS MODULATOR OF CYTOKINE LEVEL UNDER CONDITIONS OF EXPERIMENTAL IMMUNOPATHOLOGY].
Topics: Animals; Cyclophosphamide; Drug Administration Schedule; Immunity, Innate; Immunologic Factors; Immunosuppressive Agents; Inflammation; Injections, Intraperitoneal; Interleukin-1beta; Interleukin-4; Interleukin-6; Lipopolysaccharides; Male; Piracetam; Pseudomonas aeruginosa; Rats; Rats, Wistar; Th1-Th2 Balance | 2015 |
Neuroprotective and anti-inflammatory activity of DAT inhibitor R-phenylpiracetam in experimental models of inflammation in male mice.
Topics: Animals; Anti-Inflammatory Agents; Biological Availability; Brain; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Inflammation; Male; Mice; Mice, Inbred ICR; Neuroprotective Agents; Piracetam; Stereoisomerism; Tissue Distribution | 2020 |